| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Cash | 4.60 | 0.67 | 0.42 | 0.07 |
| Receivables | 20.00 | 0.00 | 0.00 | 0.01 |
| Inventory | 0.11 | — | — | — |
| Other | 3.60 | — | — | — |
| 28.55 | 0.83 | 0.60 | 0.25 |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Payables | 2.95 | 0.01 | 0.04 | 0.04 |
| ST’ Debt | 0.44 | — | — | — |
| Other | 1.33 | 12.10 | 0.29 | 0.00 |
| 9.37 | 25.12 | 2.37 | 2.02 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | 1.76 | — | — |
—
|
| ’22 | — | 2.48 | — | 0.61 |
2.94
|
| ’21 | — | — | — | 2.91 |
2.95
|
| ’20 | — | 0.98 | — | — |
1.05
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | (0.58) | — | — |
(0.82)
|
| ’24 | — | (1.63) | — | — |
(1.02)
|
| ’23 | — | 0.42 | — | — |
1.88
|
| ’22 | — | (0.99) | — | (0.35) |
(1.85)
|
| ’21 | — | (0.84) | — | (1.08) |
(1.90)
|
| ’20 | — | (0.18) | — | (0.49) |
(0.70)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | (0.58) | — | — |
(0.81)
|
| ’24 | — | (1.63) | — | — |
(1.02)
|
| ’23 | — | 0.28 | — | — |
1.74
|
| ’22 | — | (0.99) | — | (0.35) |
(1.86)
|
| ’21 | — | (0.84) | — | (1.08) |
(1.90)
|
| ’20 | — | (0.18) | — | (0.49) |
(0.70)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
(0.14)
|
| ’24 | — | — | — | — |
(0.32)
|
| ’23 | — | (0.19) | — | — |
(1.92)
|
| ’22 | — | 0.04 | — | (0.46) |
(3.52)
|
| ’21 | — | (0.55) | — | (0.41) |
(7.60)
|
| ’20 | — | 0.02 | — | 0.59 |
5.60
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 13.20 | 10.64 | 4.08 | 3.16 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 54.00 | 35.20 | 70.80 | 8.20 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 67 | 9 | 9 | 9 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.04 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue/Emp
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.94 | — | — | — | — | — | — |
Revenue
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.67% | — | — | — | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.38) | (1.18) | (0.43) | (0.18) | — | — | — |
EBT
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (80.94%) | 0.00% | 0.00% | 0.00% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.38) | (1.48) | (0.43) | (0.18) | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.37 | 0.23 | 0.05 | 0.00 | — | — | — |
Depreciation
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.88 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | (3.52) | (1.92) | (0.32) | (0.14) | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.81) | 1.83 | (0.85) | (0.65) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | (0.14) | 0.00 | 0.01 | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.81) | 1.69 | (0.85) | (0.64) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.13 | 10.45 | 9.99 | 9.82 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.02 | 1.03 | 1.21 | 1.26 | — | — | — |
Shares
|
| — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 0.00 | — | — | — | — | — | — |
PE Ratio
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.91 | — | — | — | — | — | — |
PS Ratio
|
| — | — | — | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.10 | — | — | — | — | — | — |
PB Ratio
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.84 | — | — | — | — | — | — |
EV/Sales
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (25.89) | — | — | — | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.85) | 1.88 | (1.02) | (0.82) | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | (0.15) | — | 0.01 | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.86) | 1.74 | (1.02) | (0.81) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.18 | (24.29) | (1.78) | (1.77) | — | — | — |
Working Cap'
|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.73 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.13 | (0.67) | (0.42) | (0.07) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.72 | 10.74 | 12.07 | 12.34 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (7.22%) | (4.75%) | (1.21%) | (0.50%) | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (8.74%) | (8.02%) | (5.29%) | (2.38%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (13.13%) | (10.72%) | (3.79%) | (1.44%) | — | — | — |
ROE
|
China Natural Resources, Inc. (CHNR), a China-focused mining explorer, stands as a stark warning for investors chasing resource plays. Once boasting fleeting revenue peaks—like $2.95 million in 2021 amid a tiny workforce surge—operations have ground to a halt, with zero revenue since 2022 and employees slashed 87% to just nine. Chronic losses dominate, with net income swinging wildly from profits in 2020 to deepening shortfalls, dragging returns like ROA and ROE into negative territory. The stock, down 95% from decade highs, trades as a penny stock reflecting total skepticism.
A modest balance sheet buffer—net cash position and $12 million in equity—offers slim protection against liquidity squeezes, working capital swings, and ongoing depreciation drags. No analyst targets, zero insider trades, and external headwinds like China’s mining crackdowns, trade tensions, and Nasdaq delisting fears amplify the downside. While a rare 2023 cash flow positive hints at survival mode, 2024 reversals underscore fragility.
This deep dive reveals CHNR’s squandered potential and sky-high risks—perfect for understanding why some resource bets fizzle. Read the full analysis for charts, metrics, and revival odds.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.